Ten-year patency and factors causing restenosis after endovascular treatment of iliac artery lesions

Circulation Journal

Volumn 73, Issue 5, 2009, Pages 860-866

  Koizumi, Akira ^a   Kumakura, Hisao ^a   Kanai, Hiroyoshi ^a   Araki, Yoshihiro ^a   Kasama, Shu ^a   Sumino, Hiroyuki ^a   Ichikawa, Shuichi ^a   Kurabayashi, Masahiko ^b  

^a Cardiovascular Hospital of Central Japan   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Endovascular treatment; Long term patency; Peripheral arterial disease; Stent; TransAtlantic Inter Society Consensus II

Indexed keywords

BERAPROST; CILOSTAZOL; SARPOGRELATE;

AGED; ARTERY DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENDOVASCULAR SURGERY; FEMALE; HUMAN; ILIAC ARTERY OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; RESTENOSIS; STENT; TREATMENT OUTCOME; VASCULAR PATENCY;

AGED; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; CONSTRICTION, PATHOLOGIC; FEMALE; HUMANS; ILIAC ARTERY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 65649148256     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0765     Document Type: Article

References (17)

1. Bosch JL, Hunink MG. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997; 204: 87-96. (Pubitemid 27281713)
2. Henry M, Amor M, Ethevenot G, Henry I, Amicabile C, Beron R, et al. Palmatz stent placement in iliac and femoropopliteal arteries: Primary and secondary patency in 310 patients with 2-4 year follow-up. Radiology 1995; 197: 167-174.
3. Dyet JF, Gaines PA, Nicholson AA, Cleveland T, Cook AM, Wilkinson AR, et al. Treatment of chronic iliac artery occlusions by means of percutaneous endovascular stent placement. J Vasc Interv Radiol 1997; 8: 349-353. (Pubitemid 27524126)
4. Ponec D, Jaff MR, Swischuk J, Feiring A, Laird J, Mehra M, et al. The Nitinol SMART stent vs Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial results. J Vasc Interv Radiol 2004; 15: 11-18. (Pubitemid 39249845)
5. Kamiya C, Sakamoto S, Tamori Y, Yoshimuta T, Higashi M, Tanaka R, et al. Long-term outcome after percutaneous peripheral intervention vs medical treatment for patients with superficial femoral artery occlusive disease. Circ J 2008; 72: 734-739.
6. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD): TASC Working Group: TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000; 31(Suppl 1): S1-S296. (Pubitemid 30067386)
7. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. TASC II Working Group: Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45(Suppl 1): S5-S67. (Pubitemid 46151680)
8. Guo X, Li J, Pang W, Zhao M, Luo Y, Sun Y, et al. Sensitivity and specificity of ankle-brachial index for detecting angiographic stenosis of peripheral arteries. Circ J 2008; 72: 605-610.
9. Leville CD, Kashyap VS, Clair DG, Bena JF, Lyden SP, Greenberg RK, et al. Endovascular management of iliac artery occlusions: Extending treatment to TransAtlantic Inter-Society Consensus class C and D patients. J Vasc Surg 2006; 43: 32-39. (Pubitemid 43083505)
10. Balzer JO, Gastinger V, Ritter R, Herzog C, Mack MG, Schmitz-Rixen T, et al. Percutaneous interventional reconstruction of the iliac arteries: Primary and long-term success rate in selected TASC C and D lesions. Eur Radiol 2006; 16: 124-131. (Pubitemid 43108835)
11. Timaran CH, Prault TL, Stevens SL, Freeman MB, Goldman MH. Iliac artery stenting versus surgical reconstruction for TASC (TransAtlantic Inter-Society Consensus) type B and type C iliac lesions. J Vasc Surg 2003; 38: 272-278. (Pubitemid 41123252)
12. Park KB, Do YS, Kim DI, Kim DK, Kim YW, Shin SW, et al. The TransAtlantic InterSociety Consensus (TASC) classification system in iliac arterial stent placement: Long-term patency and clinical limitations. J Vasc Interv Radiol 2007; 18: 193-201. (Pubitemid 46616704)
13. Reyes R, Carreira JM, Gude F, Górriz E, Gallardo L, Pardo MD, et al. Long-term follow-up of iliac wallstents. Cardiovasc Intervent Radiol 2004; 27: 624-631. (Pubitemid 40064548)
14. Tsetis D, Uberoi R. Quality improvement guidelines for endovascular treatment of iliac artery occlusive disease. Cardiovasc Intervent Radiol 2008; 31: 238-245.
15. Passman MA, Taylor LM, Moneta GL, Edwards JM, Yeager RA, McConnell DB, et al. Comparison of axillofemoral and aortofemoral bypass for aortoiliac occlusive disease. J Vasc Surg 1996; 23: 263-271. (Pubitemid 26070714)
16. Jacobs DL, Motaganahalli RL, Cox DE, Wittgen CM, Peterson GJ. True lumen re-entry devices facilitate subintimal angioplasty and stenting of total chronic occlusions: Initial report. J Vasc Surg 2006; 43: 1291-1296. (Pubitemid 43825696)
17. AbuRahma AF, Hayes JD, Flaherty SK, Peery W. Primary iliac stenting versus transluminal angioplasty with selective stenting. J Vasc Surg 2007; 46: 965-970. (Pubitemid 350017797)